Sven Subotič (Best Buy Investments, a.s.)
World markets  |  November 09, 2012 14:28:33

Pills for portfolio

The main "pharmacists" from Bayer are apparently satisfied with the results of the Group. The company is completing additional acquisitions and price action this year has increased by one third. Profit-taking is at the door.

The pharmaceutical group Bayer remains on course. Earnings season is in full swing. Many companies have already published their books, among them Bayer.In addition to profit, where the sinks fend litigation around drug Yaz / Yasmin and restructuring costs, all numbers exceeded analysts' expectations. EBITDA adjusted for these special events strengthened 2.2 percent to 1.85 billion euros. Turnover increased by 11.5 percent to 9.67 billion euros. Eventually gain despite increased spending reached 528 million eur.Pro this year is planned to increase in adjusted EBITDA for higher single-digit number, turnover should increase by four to five percent to 40 billion euros.
Previously announced further strategic acquisitions group. After purchasing companies Teva and AgraQuest also announced takeover Chiff Nutrition International for 1.2 billion USD. By the end of this year should be completed takeover.

Also, the share price remains in upward trend since September 2011. Later this year, the shares rise 30%, the probability of choosing profits is therefore omnipresent risk. Therefore, as an appropriate way to participate in the development of the stock exchange, offers investments through bonus certificates. Currently offers attractive conditions of BNP Paribas, for example, at maturity in June 2013 and almost 20% protection barrier in bonus offers yield in excess of 12% pa plus full participation in the growth rate of 1:1 shares this bonus income.

Author: Jaroslav Brzoň, investment strategist BBI

Tyto zprávy pro vás vytváří Best Buy Investments, a.s..
Was this article: 10 | 8 | 6 | 4 | 2 | 0

Last news from the section World markets:

Pá 22:03  Closing Bell & výhled na 24. 9. – čeká nás rušný týden Grant Capital (Grant Capital)
Pá 10:52  Pokud padnu já, padne i akciový trh Patria (Patria Finance)
Pá   9:50  OPAP: Provozní ředitel koupil akcie Research (J&T BANKA)

Pilule pro portfolio

Diskuze a názory

Na dané téma nejsou žádné názory.

Zobrazit sloupec 
Moner | ISIN database | Weather forecast
Česká verze - Akcie cz, kurzy měn, forex, zlato.
Favorite: Prague Stock Exchange Czech crown Czech economy Commodities Gold Trademarks Prague Weather

Copyright © 2000 - 2018, spol. s r.o., AliaWeb, spol. s r.o.,

ISSN 1801-8688